Engineered E. coli mass-produce key precursor to potent biofuel
New lines of engineered bacteria can tailor-make key precursors of high-octane biofuels that could one day replace gasoline, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Department of Systems Biology at Harvard Medical School report in the June 24 online edition of Proceedings of the National Academy of Sciences.
The same lines can also produce precursors of pharmaceuticals, bioplastics, herbicides, detergents, and more.
“The big contribution is that we were able to program cells to make specific fuel precursors,” said Pamela Silver, Ph.D., a Wyss Institute Core Faculty member, Professor of Systems Biology at Harvard Medical School, and senior author of the study.
New biofuels are needed for cars and other vehicles. Ethanol, the most popular biofuel on the market, packs only two-thirds the energy of gasoline, and ethanol-containing fuels also corrode pipes, tanks, and other infrastructure used to transport and store gasoline. Meanwhile, burning gasoline itself adds huge amounts of carbon dioxide to the atmosphere, and relies on the world’s dwindling supply of oil.
Yet gasoline produces more energy than current biofuels when burned in an internal combustion engine, and remains liquid in temperatures ranging from a Texas heat wave to a North Dakota cold snap. Moreover, hundreds of millions of cars worldwide are built to run on it.
Silver and her team are seeking new ways to make gasoline-like biofuels that could be stored at gas stations and used to fuel the cars we already have. To develop these, they enlisted the iconic laboratory bacterium E. coli to help make gasoline precursors called fatty acids — energy-packed molecules containing chains of carbon atoms flanked with hydrogen atoms that can be easily converted into fuels.
Specifically, they are focusing on medium-chain fatty acids — those with chains between four and 12 carbons long. Fatty acids with shorter chains do not store enough energy to be good fuels and they tend to vaporize easily, while those with chains longer than 12 carbons are too waxy. But medium-length fatty acids are just the right length to be transformed into an energy-packed liquid fuel for internal-combustion engines.
Today oil refineries produce medium-chain-length compounds from crude oil. But “instead of using petroleum products, you can have microbes or other living organisms do it for you,” Silver said.
To accomplish that, Joe Torella, Ph.D., and Tyler Ford, Harvard Medical School Systems Biology graduate students in Silver’s laboratory and the paper’s lead coauthors, tweaked an E. colimetabolic pathway that produces fatty acids. Specifically, they mass-produced an eight-carbon fatty acid called octanoate that can be converted into octane.
In this pathway, carbon from sugar, which the bacterium eats, flows through the pathway like a river, growing longer as it flows. Downstream, it exits as a long-chain fatty acid.
Torella and Ford first partially dammed the river and built an irrigation ditch using a drug that blocks enzymes that extend fatty-acid chains. This caused medium-chain fatty acids to pool behind the dam, while still allowing enough of the river to flow by for the bacteria to build their membranes and stay alive. The strategy increased octanoate yields, but the drug is too expensive for the process to be scaled up.
For that reason, the scientists tried a second strategy that could be scaled up more readily. They let the cells grow up, then dammed the river using a genetic trick. They also genetically altered a second enzyme that normally builds long-chain fatty acids such that it extends fatty acids to eight carbons and no longer.
This two-pronged strategy — plus some other genetic nips and tucks to keep the river from being diverted in other ways — gave the scientists the highest yields of octanoate yet reported.
“We found if we stop up the river — if we slow fatty acid elongation — we encouraged the creation of medium-chain fatty acids,” Torella said.
“Sustainability is one of the biggest problems we face today, and developing potent biofuels to replace gasoline is a major challenge in the field,” said Don Ingber, M.D., Ph.D., Wyss Institute Founding Director. “Using ingenious synthetic-biology strategies to engineer microbes so that they can produce octane, Pam’s team has taken a giant step toward meeting this challenge.”
The Latest Bing News on:
- The Future Of Diesel Is On Shaky Groundon April 6, 2021 at 5:00 pm
Diesel is a fuel that has had a mixed history, with varying levels of take-up by consumers around the world. In the world of transport, diesel engines have offered better fuel economy and torque ...
- Palm Oil Market | Price, Size, Analysis and Forecast 2021-2026on March 25, 2021 at 6:06 am
Besides this, palm oil is used as a feedstock in the biofuels industry for producing biodiesel and a substitute for mineral oil in power plants. The rising environmental concerns, along with ...
- Plant oils will replace petroleum in coming yearson December 12, 2018 at 10:51 am
Although most biofuel discussions center on ethanol ... "Coconut oil, tropical oils and similar plant oils might make a reasonable gasoline-like fuel. It might also be possible to transgenetically ...
- Chu announces carbon sequestration funding; stresses importance of energy crops, ag residueon February 5, 2010 at 2:24 pm
"A conservative estimate says we can replace half our gasoline with biofuels, of which half we can generate ... so that if you feed them simple sugars, they would produce gasoline-like and diesel-like ...
The Latest Google Headlines on:
The Latest Bing News on:
- Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meetingon April 10, 2021 at 6:37 am
CAMBRIDGE, Mass., April 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today presented ...
- Synthetic Biology Market Emerging Trends, Opportunity Assessment, Competitive Landscape, Segmentation and Industry Outlook 2026on April 9, 2021 at 3:13 am
The MarketWatch News Department was not involved in the creation of this content. Apr 09, 2021 (Market Insight Reports) -- The Synthetic Biology Market is estimated to reach USD 17.36 Billion by 2026, ...
- New research finds a natural blue that could replace artificial colorson April 8, 2021 at 1:43 pm
We used synthetic biology and computational design tools to determine the structure of the anthocyanin, which, thanks to its unique 3D inter-molecular arrangement, can be altered to produce a rare ...
- Oxy subsidiary, Cemvita hope to produce bio-ethyleneon April 7, 2021 at 12:22 pm
Oxy Low Carbon Ventures, created in 2018, and Cemvita Factory, launched in 2017 to help decarbonize industries with synthetic biology, will build and operate a bio-ethylene plant at Cemvita’s Houston ...
- Synthetic Biology and the Future of Food, Fashion and Pharmaon April 7, 2021 at 10:50 am
The synthetic biology revolution is here! In this presentation we are excited to bring together leaders in the field for the April episode of GEN Live, to discuss where the field is now and the ...
- Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratorieson April 7, 2021 at 9:00 am
About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the ...
- Global Synthetic Biology Technology Market 2021 Sales Channels, Technology and Production Analysis, Business Growth by 2026on April 7, 2021 at 4:42 am
The MarketWatch News Department was not involved in the creation of this content. Apr 07, 2021 (CDN Newswire via Comtex) -- Global Synthetic Biology Technology Market 2021 by Company, Regions, Type ...
- Twist Bioscience Earns 2021 Great Place to Work Certification™on April 5, 2021 at 5:01 am
To learn more about working at Twist, please visit our Careers site. About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that ...
- Artificial Life Forged in a Lab? Scientists Create Synthetic Cell That Grows and Divides Normallyon April 2, 2021 at 8:44 am
New findings shed light on mechanisms controlling the most basic processes of life. Five years ago, scientists created a single-celled synthetic organism that, with only 473 genes, was the simplest ...
- Scientists develop synthetic cell that grows and divides uniformlyon April 2, 2021 at 12:02 am
This is the first time that the cell division cycle has been mimicked successfully in an artificial cell, marking a breakthrough in synthetic biology. Artificial or synthetic cells are essentially ...